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Case presentation
Dr Pechet: The patient is a 76-year-old woman who
was previously in good health except for a history of
hyperthyroidism, arthritis, and hypertension. She is a
lifelong nonsmoker. She presented with a history of 6
months of progressive weakness, peripheral edema,
and dyspnea on exertion to the point that she could no
longer walk more than 10 to 15 feet. She had only min-
imal improvement with a trial of diuretics. Pulmonary
function tests demonstrated a forced vital capacity of
74% and a forced expiratory volume in 1 second of
82% predicted with an arterial PO2 of 62 mm Hg while
breathing room air. An electrocardiogram showed right
atrial enlargement and right axis deviation. She also
had a chest radiograph.
Dr Glazer: The chest radiograph shows moderate
enlargement of the cardiac silhouette. The aorta is tor-
tuous and mildly dilated. There is right paratracheal
widening, which may be due to a dilated superior vena
cava (SVC). Enlargement of the main pulmonary artery
is seen. The lungs are clear.
Dr Pechet: The patient then had a ventilation-perfu-
sion scan because her physicians were concerned that
she had had a pulmonary embolism. 
Dr Yu: The ventilation-perfusion images performed
in August 1999 demonstrate normal ventilation and
globally decreased perfusion to the right lung (Fig 1).
There are no segmental perfusion abnormalities to sug-
gest pulmonary embolism. The global decrease sug-
gests a central mass compressing the right pulmonary
vasculature and decreasing blood flow. A subsequent
ventilation-perfusion study from December 1999 again
shows normal ventilation and the same global decrease
in perfusion to the right lung (Fig 2). In addition, it
demonstrates some peripheral wedge-shaped defects,
which raise the possibility of superimposed pulmonary
embolism. 
Dr Patterson: Dr Pechet, was there some thought
that this patient had acute pulmonary emboli?
Dr Pechet: That was the original suspicion that led
to the ventilation-perfusion study. Her physicians then
obtained a spiral computed tomographic (CT) scan. 
Dr Glazer: The SVC is dilated (Figs 3 and 4). There
is focal narrowing and thickening of the wall of the left
pulmonary artery. Thickening of the wall of the
descending thoracic aorta also is noted. The right pul-
monary artery is markedly narrowed with associated
wall thickening. Normal sized lymph nodes are seen.
No pulmonary emboli are seen. Images of the lung
parenchyma are normal. There are no peripheral opac-
ities that might represent peripheral infarcts. The above
findings are most consistent with a vasculitis. The dif-
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Fig 1. Posterior pulmonary perfusion image in August 1999 demonstrates globally decreased perfusion of the right
lung. The ventilation images (not shown) were normal.
Fig 2. Posterior pulmonary perfusion image in December 1999 shows decreased perfusion of the right lung. A seg-
mental perfusion defect (arrow) is also noted in the apical subsegment of the left upper lobe.
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ferential diagnosis would also include fibrosing medi-
astinitis, but in most of those cases there would be
more evidence of a soft tissue mass or infiltration of the
mediastinum with lymph node calcifications.
Dr Patterson: Dr Glazer, could you make a com-
ment about CT scans in the evaluation of pulmonary
embolism? What is the role of the pulmonary angio-
gram? What is the role of CT imaging?
Dr Glazer: Helical CT has increasingly been used to
evaluate patients in whom pulmonary emboli are sus-
pected. It can accurately diagnose emboli in segmental
or larger vessels. Although it is not as accurate in iden-
tifying subsegmental emboli, improvements in tech-
nique should allow more accurate identification of
these emboli. Moreover, the clinical importance of iso-
lated subsegmental emboli is uncertain. CT has been
particularly helpful in those cases in which the ventila-
tion-perfusion scan indicates an intermediate probabil-
ity of pulmonary embolism or in which multiple abnor-
malities are seen on the chest radiograph. Most
important, the role of helical CT should be based on the
results of multicenter outcome studies that compare its
value relative to more conventional approaches. Dr
Siegel, would you like to comment?
Dr Siegel: Overall, your answer is quite balanced,
given the state of flux of our knowledge. There need to
be better controlled multicenter comparison studies of
ventilation-perfusion imaging and CT. The National
Heart, Lung, and Blood Institute has recently decided
to fund a study labeled “PIOPED II,” in which we will
be participating. This study as proposed is primarily a
comparison of helical CT with ventilation-perfusion
imaging, with a substantial focus on outcome data
rather than just the correlation with the results of pul-
monary arteriography. In the final analysis, outcome
data are much more important. It has been known for
quite a long time that some fraction of patients with so-
called “low-probability” lung scans actually have small
pulmonary emboli, typically in the subsegmental ves-
sels. Depending on one’s perspective, these could be
considered “false-negative” lung scans. On the other
hand, a moderately large body of data shows if untreat-
ed patients with low-probability lung scans are moni-
tored, the frequency of subsequent events attributable
to pulmonary embolism is at a very low level.1 The
concept of clinically insignificant pulmonary embolism
is thus suggested. It has been argued that the pul-
monary circulation was designed the way it was, with
rich collateral connections at the microvascular level,
in part to remove the “detritus” coming from the lower
extremities. Despite this, ventilation-perfusion studies
have been criticized because of these apparent “miss-
es.” Now CT comes on the scene and the data show that
CT cannot evaluate those small vessels. The mantra is
that those small emboli are not important. I think we
are going to find as we gather more data that the truth
lies somewhere in the middle. There is likely to be a
subset of patients we can evaluate very quickly and
very safely, with a lower radiation dose, lower expense,
and no need for iodinated contrast agents by use of ven-
tilation-perfusion imaging, whereas in other patients it
will be entirely appropriate to proceed directly to CT.
Dr Glazer: It is important that the clinicians discuss
their individual cases with the radiologist to determine
which imaging test is most appropriate depending on
the clinical circumstances.
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Figs 3 and 4. The superior vena cava (V) is dilated. Focal narrowing and thickening of the walls of the left pul-
monary artery and right pulmonary artery (arrows) is seen. Thickening of the wall of the descending aorta (DA) is
also noted. No pulmonary emboli are seen.
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Dr Cooper: That is especially true in patients with
emphysema who often have a number of ventilation
defects on nuclear lung scan. My sense is if a CT scan
is positive it might be more convincing in this particu-
lar setting than an indeterminate ventilation-perfusion
scan. For patients who do not have postoperative x-ray
changes showing infiltrates or effusions, I do not know
which is better. 
Dr Safdar: Which patients do you recommend have
ventilation-perfusion scans and which patients do you
recommend undergo spiral CT scan?
Dr Siegel: I do not know the exact answer to that.
Certainly the average patient with symptoms suggest-
ing acute pulmonary embolism who has a relatively
normal chest radiograph and no known history of
severe chronic lung disease is the perfect candidate
for obtaining a quick answer with ventilation-perfu-
sion imaging. The decision becomes more complicat-
ed in the presence of radiographic infiltrates or large
pleural effusions. In those cases, it may be reasonable
to proceed directly to spiral CT. However, remember
how this clinical scenario plays out now in many
cases. Results of the lung scan are abnormal because
of the radiographic abnormalities. By the strict crite-
ria, we interpret the study as indicating an intermedi-
ate probability of pulmonary embolism. The referring
physician then reasons that the patient was really
believed to have pneumonia or congestive heart fail-
ure, but the lung scan was obtained to exclude pul-
monary embolism as an alternative treatable cause of
the signs and symptoms. The vast majority of such
patients do not undergo pulmonary arteriograms, and
we do just fine in treating them. We are not missing
large numbers of patients with hidden pulmonary
embolism by use of this strategy. Although it is obvi-
ously reasonable to try to get to a more precise diag-
nosis in as many patients as possible, we should not
fault ourselves if we use good clinical judgment and
have a good outcome despite some level of diagnos-
tic uncertainty. 
Dr Safdar: I agree. If there is an intermediate prob-
ability ventilation-perfusion scan, would you do a spi-
ral CT scan or would you go to a pulmonary
angiogram?
Dr Siegel: I would probably do a spiral CT under
those circumstances. In fact, much of the literature
argues that spiral CT is more likely to supplant pul-
monary arteriography for definitive evaluation than it
is to supplant ventilation-perfusion scintigraphy as
the screening test. A study published by Wells and
associates2 from McMaster University in 1998 shows
that by use of relatively simple pieces of readily
available clinical data for assessment of the prior
probability of pulmonary embolism, in combination
with ventilation-perfusion imaging, a strategy for
diagnostic evaluation and management can be
devised in which arteriography will be needed in only
a small percent of patients and in which outcome is
very good. This exemplifies the type of strategy that
we need to use; we need to apply it to spiral CT, we
need to apply it to ventilation-perfusion imaging, and
we need to look at various costs (including radiation
doses). I believe that when this type of analysis has
been done, we will end up with some level of use of
both tests. Right now we do not have good enough
data to tell you precisely what you ought to be doing,
and many current opinions are dogmatic and not
based on hard evidence.
Dr Safdar: In this institution, if the house staff sus-
pects pulmonary embolism they request a spiral CT. Do
you have any idea what percent of those turn out to be
positive?
Dr Glazer: Approximately 20%. 
Dr Siegel: We are still doing between 10 and 15 ven-
tilation-perfusion studies daily.
Dr Glazer: Approximately 3 to 5 helical CT pul-
monary embolism protocols are performed per day.
Dr Sundt: I should also note that Dr Glazer and his
colleagues have been quite interested in exploring the
use of spiral CT scanning with 3-dimensional recon-
struction in the evaluation of our patients with chronic
thromboembolic disease before undertaking throm-
boendarterectomy.
Dr Siegel: I have just one more point about the case
at hand. I have not seen the original interpretation of
the outside lung scan, but if the CT was done to evalu-
ate for pulmonary embolism based on the results of the
lung scan, this was not really appropriate. The lung
scan, as Dr Yu indicated, should have been interpreted
as most consistent with a disorder causing extrinsic
obstruction of either the pulmonary arteries or pul-
monary veins rather than pulmonary embolism.
Unilateral whole-lung hypoperfusion is a very atypical
pattern for pulmonary embolism. 
Dr Glazer: In some cases, the ventilation-perfusion
scan is the initial test to suggest a central obstructing
mass by demonstrating unilateral hypoperfusion. 
Dr Pechet: The next step in the patient’s workup
was a right heart catheterization, which demonstrated
pressures of 80/25 mm Hg in the proximal pulmonary
artery. Bilateral pulmonary artery stenoses, 80% left
and 90% right, were identified with a 50 mm Hg gra-
dient. The patient was then taken to the operating
room with a presumed diagnosis of fibrosing medias-
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tinitis for a cervical mediastinoscopy. The pathology
report revealed only peripheral nerve. The diagnosis
at this point was that of neurogenic tumor. The
patient was subsequently referred to Dr Cooper.
Dr Cooper: The outside pathologist saw neural tis-
sue and was considering a diagnosis of neurosarcoma.
The outside slides were reviewed here.
Dr Ritter: Eight negative lymph nodes specimens
were submitted. In addition, a specimen labeled “left
paratracheal mass” showed some benign lymph node
tissue and an unremarkable peripheral nerve.
Dr Cooper: I asked the surgeon whether by any
chance the patient was hoarse after the medi-
astinoscopy, and he said, as a matter of fact, yes.
Dr Pechet: At that time she was transferred here. She
underwent her first transthoracic echocardiogram,
which demonstrated no abnormalities of the left side of
the heart. The right side of the heart was markedly
dilated and hypokinetic. She had moderate tricuspid
regurgitation and a 60 mm Hg gradient immediately
above the pulmonary valve. After this she was taken to
the operating room by Dr Cooper and Dr Sundt for
mediastinal exploration. 
Dr Cooper: After the sternotomy, no gross abnor-
malities were visible. On palpating the main pul-
monary artery from its origin to the bifurcation, we
encountered a point at which the artery became very
firm with a rigid, thick shelf within the wall of the
artery. This felt like a mass within the wall of the pul-
monary artery itself. Most important, when palpating
outside the pulmonary artery, around it and around the
left and the right pulmonary arteries, we detected no
process extending outward from the adventitia. That is,
there was a normal plane between the artery and the
surrounding tissue. The first few centimeters of the pul-
monary artery seemed normal on palpation, and after a
few centimeters this thick shelf could be felt inside the
lumen. However, there was no inflammation or fibrosis
outside the artery. I have never seen fibrosing medias-
tinitis involve only the lumen of the vessel and not
extend into the vessel from a surrounding inflammato-
ry mass, which was not present here. 
Dr Patterson: Was a transesophageal echocardio-
gram (TEE) performed in the operating room?
Dr Skubas: Invasive intraoperative monitoring
included an arterial line, a central venous pressure line,
and TEE. TEE before repair revealed dilatation of the
hepatic veins, right atrium (transverse diameter 7 cm),
and coronary sinus and an interatrial septum that was
bulging toward the left. There was 1+ central jet of tri-
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Fig 5. Continuous wave Doppler TEE before repair depicting tricuspid regurgitation. The estimated right ventricu-
lar end-systolic pulmonary artery pressure is 66 mm Hg.
cuspid regurgitation, and the systolic pulmonary artery
pressure was calculated to be 66 mm Hg (Fig 5).
Examination of the main pulmonary artery and its
bifurcation did not reveal any thrombus. Doppler exam-
ination revealed impaired early diastolic filling of the
right ventricle (hepatic venous flow systolic/diastolic
ratio greater than 1; Fig 6). The left ventricular filling
pattern revealed a transmitral early to late velocities
ratio less than 1 and a pulmonary venous flow sys-
tolic/diastolic velocities ratio greater than 1, consistent
with relaxation abnormality. 
Dr Sundt: We performed the operation using nor-
mothermic cardiopulmonary bypass without cardio-
plegic arrest. We thought that this approach would pro-
vide us with optimal exposure for diagnostic purposes
and would allow us to be certain that we were con-
structing our anastomoses in regions free of disease.
We were thereby also able to avoid placing clamps on
these fragile vessels. Previously, we have relieved pul-
monary artery obstruction due to sarcoma by
endarterectomy with good results; however, in this case
we were reluctant to attempt the same in the absence of
a diagnosis. We were also concerned that there might
not be a satisfactory dissection plane and that we would
create an unreconstrucible mess. It seemed more
straightforward to simply place separate ringed polytet-
rafluoroethylene (PTFE) grafts* to each distal pul-
monary artery from the proximal main pulmonary
artery. 
The distal anastomosis to the left pulmonary artery
was at the pericardial reflection approximately 1 cm
beyond the gross disease. We placed the distal anasto-
mosis to the right pulmonary artery between the SVC
and the aorta. This also was well beyond the gross dis-
ease, and we thought that placing it medial to the SVC
offered several advantages: it put us proximal to the
takeoff of the right upper lobe branch and therefore still
in a segment of the vessel with a large diameter, and it
avoided the risk of compression of the SVC between
the ringed PTFE graft and the aorta. 
The proximal anastomosis of each graft was to the
main pulmonary artery. When we opened the proximal
main pulmonary artery, the wall itself appeared entire-
ly normal, but just distal to the arteriotomy we could
see a bluish mass within the lumen involving the back
wall and the more distal main pulmonary artery. We
took multiple, deep biopsy specimens of the mass and
sent them for frozen section examination. Because the
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Fig 6. Continuous wave Doppler TEE before repair of the hepatic veins. The systolic (S) to diastolic (D) ratio is
greater than 1. 
*Gore-Tex graft; registered trade name of W. L. Gore & Associates,
Inc, Flagstaff, Ariz.
proximal main pulmonary artery did not appear
involved, we used our arteriotomy site for one of the
proximal anastomoses and created a second arterioto-
my for the other graft. Although the potential for exten-
sion of the disease process to involve these sites exists,
we thought that this was simpler than proximal anasto-
mosis to the right ventricle itself and that it preserved a
valve in the system.
Dr Skubas: TEE examination after the repair
revealed a decrease in the size of the right atrium, with
minimal (trace) tricuspid regurgitation, and the calcu-
lated systolic pulmonary artery pressure was decreased
to 24 mm Hg (Fig 7). Doppler examination demon-
strated a marked recovery of the early diastolic filling
of both the right ventricle (hepatic venous flow sys-
tolic/diastolic velocities ratio less than 1, Fig 8) and left
ventricle (transmitral early to late ratio greater than 1
and pulmonary venous flow systolic/diastolic ratio less
than 1).
The TEE was used as a quantitative and qualitative
diagnostic tool in this case. First, because of the bilat-
eral pulmonary artery stenoses, a pulmonary artery
catheter was not inserted, and the TEE Doppler exami-
nation was used to calculate the systolic pulmonary
artery pressure before the procedure, as well as after
the repair. In this way, TEE proved the adequacy of
repair, as it demonstrated decrease in pulmonary artery
pressures after the bypass. Second, the TEE examina-
tion demonstrated the relative clinical signs of
increased afterload of the right ventricle: dilatation of
the right atrium, hepatic veins, and coronary sinus, as
well as tricuspid regurgitation. Third, the TEE exami-
nation of the hepatic venous flow and the pulmonary
venous and transmitral flow revealed improved filling
of the right and left ventricles, respectively.
Dr Pechet: Fig 9 shows an operative photograph
depicting what Dr Sundt described. The right and left
end-to-side 12-mm ringed PTFE bypass grafts to the
distal pulmonary artery are seen. Postoperatively, the
patient did quite well and was discharged home on
postoperative day 4 after medialization of the vocal
chord. Dr Ritter reviewed the pathology for us.
Dr Ritter: The frozen specimen was really quite
interesting, with the expectation that perhaps this was
going to be a pulmonary artery sarcoma. When we did
the frozen section, it showed the media of the artery
wall (Fig 10), which accounts for the fact that the spec-
imen looks “striped,” with inflammatory cells just
tracking through along the pre-existing elastic tissue of
the media. That is all that the frozen section showed;
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Fig 7. Continuous wave Doppler TEE after repair. The tricuspid regurgitation jet is significantly reduced. The esti-
mated systolic pulmonary artery pressure is 24 mm Hg.
there was nothing that looked neoplastic. Fig 11 shows
more of this inflammatory tissue, which is fibrotic, sug-
gesting that it had been present for some time. The
specimen actually contained small vessels, which are in
tissue that Dr Cooper assured us came from the inside
of the pulmonary artery. Thus, some small systemic
arteries have actually formed in the pulmonary artery
lumen. In other areas the tissue showed the sort of
foam-cell change that might be seen in an atheroscle-
rotic plaque (Fig 12). On the permanent sections of the
tissue that had been frozen are plasma cells; Fig 13
shows their eccentric nucleus and amphophilic cyto-
plasm. At the time that we saw the frozen section, I did
not think this was neoplastic; we were considering per-
haps an inflammatory pseudotumor, which has rarely
been reported to occur in the lung as an intra-arterial
lesion and can actually mimic pulmonary emboli.
Nonetheless, we were not completely sure what we
were dealing with when we were examining the frozen
section. 
When we got to the permanent sections, the picture
became more clear. There were abscess-like areas, with
some granulomas and some palisading histiocytes (Fig
14). Again, we observed giant cells and areas of necro-
sis. Fig 15 shows an area of necrosis with some puru-
lent debris containing neutrophils and then a palisade
of histiocytes and giant cells around the outside of this
focus. This was located right in the pulmonary artery
media, so it is actually an area of medial necrosis with
a granuloma around it. Some of these necrotic areas
appeared to contain pieces of elastic tissue; that occurs
with necrosis of a vessel wall. Therefore, we thought
this was a granulomatous arteritis. The types of large
vessel arteritis that can develop in the pulmonary arter-
ies are all quite unusual but include Takayasu arteritis,
giant cell arteritis, rheumatoid vasculitis, and even
Wegener granulomatosis. With the granulomas, acute
inflammatory foci, and fibrosis, I think this looks his-
tologically most like Takayasu arteritis. It certainly is
an unusual presentation, since almost all patients with
Takayasu arteritis have been reported to be younger
than 40 or certainly younger than 50 years of age.
Nonetheless, with apparent involvement of the aorta
and the histologic characteristics, the evidence looks
reasonably convincing for that entity.
Dr Cooper: Dr Glazer, there were two CT scans, 6
months apart. Did you review those?
Dr Glazer: No.
Dr Cooper: We had gotten the old CT scan from
August and could see no changes between the two,
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Fig 8. Continuous wave Doppler TEE after repair of the hepatic venous flow (HVF). The systolic/diastolic (S/D)
ratio is now less than 1.0.
which encouraged us. I asked her family how long in
retrospect they thought that she had been symptomatic.
They said she used to tool around her large farm with
no problem at all; in the past 3 or 4 years there had been
a decline, but for a woman in her mid-70s, it is hard to
know how much can be attributed to advancing years.
However, she had changed from a very energetic active
person to someone who could hardly walk. 
Dr Roper: I have a question for pathology. I have
seen only one primary tumor in the pulmonary circu-
lation, and that was a number of years ago in a patient
from Columbia, Missouri. His left pulmonary artery
tumor was termed a hemangiopericytoma. What
would the microscopic examination reveal? I have
seen mediastinal fibrosis involving the pulmonary
artery.
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Fig 9. Operative photograph shows the separate ringed PTFE grafts from the main pulmonary artery to the right
and left pulmonary arteries (head is to the left).
Fig 10. Tissue submitted for frozen sections showed inflammatory cells in arterial media; the tracking of inflam-
matory cells between the elastic and muscular layers imparts a “striped” appearance.
Dr Ritter: The pulmonary artery sarcomas are really
a mixed bag of tumors. Most of them look like some
type of smooth muscle tumor—leiomyosarcoma, for
example. Other tumors can only be called high-grade
spindle cell malignant tumors. Others may resemble
hemangiopericytoma. 
Dr Roper: That was the diagnosis in the one I saw.
Dr Ritter: Another concern about these so-called pul-
monary artery sarcomas is whether they might be metas-
tases that get lodged in the pulmonary artery. Once that
possibility has been excluded, a variety of conditions get
lumped under the term pulmonary artery sarcoma that
represent a variety of soft tissue sarcomas.
Dr Cooper: Dr Glazer, how did you interpret the
thickening around the descending aorta? We noticed in
advance a concentric thickening of the aortic wall. 
Dr Glazer: Thickening of the wall of the descend-
ing aorta, in association with thickening of the walls
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Fig 11. Additional frozen section tissue showed inflamed fibrous tissue, as well as the presence of systemic capil-
laries.
Fig 12. Sections of the intra-arterial tissue showed inflamed fibrous tissue, as well as foamy histiocytes.
of pulmonary arteries, is highly suggestive of a vas-
culitis.
Dr Cooper: Is that an acceptable radiologic picture
for Takayasu arteritis? 
Dr Glazer: Yes.
Dr Cooper: I was initially worried that we missed
something, that maybe the biopsies were not deep
enough.
Dr Ritter: No, you have clearly gotten into the
media, because those inflammatory cells can be seen
tracking through the media and there are necrotizing
granulomas in the middle of that. I am pretty sure this
is representative of the pathologic process.
Dr Patterson: How is Takayasu arteritis treated?
Dr Pechet: The primary treatment for Takayasu
arteritis is immunosuppression. The response rate to
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Fig 13. Abundant plasma cells were present within the media; typical features of plasma cells include an eccentric
nucleus, amphophilic cytoplasm, and perinuclear halos.
Fig 14. Necrosis with abscess-like pattern, including neutrophils in the necrotic debris. There is a surrounding pal-
isade of histiocytes.
glucocorticoids is highly variable, ranging from 20% to
100%. In patients with steroid-resistant disease,
methotrexate, cyclophosphamide, and azathioprine
have all been used with some success.
Dr Patterson: Is it a lethal condition? 
Dr Pechet: Takayasu arteritis is rarely fatal, although
myocardial failure, renal failure, stroke, and aneurysm
rupture have been reported as causes of death.
Dr Sundt: Occasionally patients will die of the
sequela of their occlusive disease. Most often, the bra-
chiocephalic vessels are involved and patients may
undergo synthetic graft reconstruction for cerebrovas-
cular insufficiency. Unfortunately, the condition may
be progressive, with ultimate occlusion of those grafts
with anastomotic or distal disease. It may also lead to
lower extremity or visceral ischemia necessitating
peripheral vascular bypass.
Dr Cooper: What fraction of patients have involve-
ment primarily of the pulmonary arteries?
Dr Ritter: As Dr Glazer said, involvement of the pul-
monary arteries has been reported and the number or
percentage of patients who have pulmonary artery
involvement varies from study to study. In some of the
Japanese studies, in which pulmonary angiograms have
been obtained on everybody with the diagnosis, most of
the time the patients had some kind of involvement of
the pulmonary arteries, although clinically that would
not necessarily have been suspected. 
Dr Pechet: As Dr Ritter said, most of this literature
is from Japan. Although a wide range has been report-
ed, approximately 50% of cases of Takayasu arteritis
involve the pulmonary artery.3 There are also cases of
isolated pulmonary artery involvement at presenta-
tion.4 Most often, the disease is more peripheral than
in this case.
Dr Roper: Dr Siegel, what do ventilation-perfusion
scans typically show in Takayasu arteritis? Is this case
typical?
Dr Siegel: I have not seen a presentation like this. We
have seen several cases of Takayasu arteritis, and they
have involved lobar and segmental pulmonary arteries;
the appearance simulates that of pulmonary embolism,
as reported by others.5
Dr Cooper: How were these cases diagnosed, by
biopsy or excision?
Dr Siegel: They were diagnosed by arteriography
after ventilation-perfusion imaging. I do not know how
many of those cases involved biopsies.
Dr Cooper: Then how could you make the diagnosis?
Dr Siegel: The arteriogram shows a typical smooth
region of narrowing involving a long segment of the
artery. This appearance suggests arteritis, and large-
vessel involvement is typical of Takayasu arteritis. The
patients we have seen were the typical young women
with no evidence of other problems to suggest another
systemic vasculitis, such as polyarteritis nodosa, which
can have similar pulmonary arterial involvement. In the
cases I recall, there also was aortic or aortic branch
involvement and the ventilation-perfusion findings
looked like those of pulmonary embolism.
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Fig 15. A higher power view shows necrotic and purulent debris, with surrounding histiocytes and giant cells.
There is a serpentine elastic fiber with the necrotic debris (arrow).
Dr Patterson: This case was presented yesterday at
the chest radiology conference. The point was made
that in patients who were known to have Takayasu
arteritis, a detailed prospective search of the pulmonary
circulation shows that the incidence of pulmonary
involvement is really very high. Does this patient have
aortic involvement too?
Dr Cooper: Yes. We knew that the aortic wall was
abnormal, but we did not know what the abnormality
was and whether it was related to the obstructing pul-
monary artery lesions. I had been sent the CT scans in
advance, and I thought the appearance suggested a sar-
coma. When the patient decided to come here, I told
her doctors that (1) I could not promise that we could
do any more at all and she might waste a trip and (2) if
we did do something surgical for her she might add
only 1 or 11⁄2 years to her life because the tumor was
probably a slowly growing sarcoma and the best we
could do was to buy some time for her. 
Dr Sundt: She does not, however, have known
involvement of the brachiocephalic vessels. 
Dr Roper: Will you prescribe anticoagulation for the
rest of her life?
Dr Pechet: There is not an established role for anti-
coagulant or antiplatelet therapy in treating Takayasu
arteritis. She has, however, been placed on a regimen of
long-term warfarin (Coumadin) therapy to maintain
patency of the bypass graft.
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